Cerus | CERS - Ebitda

Harga Saham
1.95
Perubahan Harian
0.06 3.17%
Bulanan
8.33%
Tahunan
43.38%
Q2 Perkiraan
1.84




Ebitda Perubahan Tanggal
GRIFOLS EUR 347.24M 58.35M 2025-06
Haemonetics USD 115.53M 9.22M 2025-09
Neogen USD 48.2M 546K 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Plus Therapeutics USD -4.4M 2.94M 2025-09
Quidel USD 153.3M 23.8M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12
Terumo JPY 69.99B 3.22B 2025-12